Some authors have described that the inhibition of the TLR4/NF-κB signaling pathway, which is related to inflammatory response in chronic liver damage, also helps to protect hepatocytes against steatosis and fibrosis [59,60]. The gene discussed is NFKB1; the disease is steatosis.